Clinical Trials · NCT03455322
Norepinephrine Infusion Versus Midodrine & Octreotide in Patients With Hepatorenal Syndrome Type 1.
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- National Hepatology & Tropical Medicine Research Institute
- Enrollment
- 60
- Start date
- Aug 2018
- Locations
- 1 site, Egypt
- Primary endpoint
- the proportion of patients achieved full response